Vaccines 2013, 1(3), 343-347; doi:10.3390/vaccines1030343
Opinion

Trust in Vaccines: Why It Takes More than Good Faith

Chief Medical Officer, GlaxoSmithKline Vaccines, Avenue Fleming, 1300 Wavre, Belgium
Received: 29 May 2013; in revised form: 21 June 2013 / Accepted: 10 July 2013 / Published: 12 August 2013
(This article belongs to the Special Issue Confidence in Vaccines)
PDF Full-text Download PDF Full-Text [218 KB, uploaded 12 August 2013 10:51 CEST]
Abstract: This Vaccines issue on “Confidence in Vaccines” provides sound evidence through multiple perspectives of life-saving impacts when vaccination programs are effectively implemented in a population. Yet there remain challenges to achieving this impact, including scientific, medical, manufacturing, policy-related and logistical issues. Additionally, socio-cultural, religious and political agendas can come into play, taking public health hostage and sometimes allowing the circulation of myths regarding vaccination. All of these challenges play a role in public confidence in vaccines and vaccination. What we trust, we embrace. What we do not trust, we do not embrace.

Article Statistics

Load and display the download statistics.

Citations to this Article

Cite This Article

MDPI and ACS Style

Begg, N. Trust in Vaccines: Why It Takes More than Good Faith. Vaccines 2013, 1, 343-347.

AMA Style

Begg N. Trust in Vaccines: Why It Takes More than Good Faith. Vaccines. 2013; 1(3):343-347.

Chicago/Turabian Style

Begg, Norman. 2013. "Trust in Vaccines: Why It Takes More than Good Faith." Vaccines 1, no. 3: 343-347.

Vaccines EISSN 2076-393X Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert